IHC-P analysis of human breast invasive ductal carcinoma tissue using GTX27293 TGF alpha antibody. Working concentration : 0.5 microg/ml Antigen retrieval : Heat induced antigen retrieval with a pH 6.0 Sodium Citrate buffer.
IHC-P analysis of human breast invasive ductal carcinoma tissue using GTX27293 TGF alpha antibody. Working concentration : 0.5 microg/ml Antigen retrieval : Heat induced antigen retrieval with a pH 6.0 Sodium Citrate buffer.
TGF alpha antibody
GTX27293
ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
Product group Antibodies
ReactivityHuman
TargetTGFA
Overview
- SupplierGeneTex
- Product NameTGF alpha antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 0.1 - 0.2 microg/mL. ELISA: 0.5 microg/mL. Neutralizing/Inhibition: 0.1 - 0.15 microg/mL. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID7039
- Target nameTGFA
- Target descriptiontransforming growth factor alpha
- Target synonymsprotransforming growth factor alpha; TFGA; TGF-alpha
- HostRabbit
- IsotypeIgG
- Protein IDP01135
- Protein NameProtransforming growth factor alpha
- Scientific DescriptionTransforming Growth Factor-alpha (TGFa), originally discovered in 1978 in conditioned medium of retrovirus-transformed fibroblasts (ref 1), is a protein that reversibly confers a transformed phenotype upon normal non-neoplastic cells, such as normal rat kidney (NRK) fibroblasts (ref 2). The transforming activity of TGFa was later shown to require the presence of Transforming Growth Factor-beta, which potentiates the action of TGFa via a separate receptor (ref 2-4).
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203